Biotech Acquisition Co

Biotech Acquisition Co (Nasdaq: BIOT) is a blank-check company formed to pursue a merger or acquisition target in the biotechnology and life sciences sector. The company filed a Form 10-Q with the SEC on May 16, 2022, under accession number 0001213900-22-027093, reflecting its active search phase during that period. Focused on the biotech industry, BIOT sought to identify and complete a business combination with a company operating in healthcare innovation or pharmaceutical development. The sponsor name has not been independently confirmed in available public disclosures. For complete filing history, deal status, and sponsor details on BIOT and hundreds of other SPACs, sign up for full data access at SpacDesk.